<img alt="" height="1" width="1" />
Roche melanoma drug helps patients live longer
ZURICH (Reuters) - Roche Holding AG&#39;s promising new drug for patients with advanced skin cancer helps patients to live longer and without their disease getting worse, a late-stage trial has shown. The news is likely to give Roche a boost as its ...
Plexxikon, Roche Drug Extends Lives in Patients With Deadly Skin CancerXconomy
Plexxikon Reports Overall Survival Benefit for Melanoma Patients in PLX4032 ...Business Wire (press release)

all 13 news articles &raquo;